Non-viral gene delivery nanoparticles based on Poly(β-amino esters) for treatment of glioblastoma

Biomaterials

Volumn 32, Issue 23, 2011, Pages 5402-5410

  Tzeng, Stephany Y ^a   Guerrero Cázares, Hugo ^a   Martinez, Elliott E ^a   Sunshine, Joel C ^a   Quinones Hinojosa Alfredo A ^a   Green, Jordan J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; DNA; Drug delivery; Gene therapy; Nanoparticle; Stem cell

Indexed keywords

AMINO ESTERS; CANCER; CLINICAL SETTINGS; COCULTURE; DEGREE OF SPECIFICITY; GLIOBLASTOMAS; IN-VITRO; NEURAL STEM CELL; NON-VIRAL GENE DELIVERY; SURVIVAL RATE; TRANSFECTION EFFICIENCY; TUMOR CELLS;

BIODEGRADABLE POLYMERS; BODY FLUIDS; CELL CULTURE; DRUG DELIVERY; GENE TRANSFER; NANOPARTICLES; NUCLEIC ACIDS; STEM CELLS; TUMORS;

GENE THERAPY;

EPIDERMAL GROWTH FACTOR; NANOPARTICLE; PLASMID DNA; POLYMER;

ARTICLE; ASTROCYTE; CELL SPECIFICITY; CELL TYPE; CENTRAL NERVOUS SYSTEM TUMOR; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FETUS; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; NEURAL STEM CELL; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; TRANSGENE; TUMOR CELL;

ASTROCYTES; CARBOCYANINES; CELL LINE, TUMOR; CELL SURVIVAL; CRYOPROTECTIVE AGENTS; DNA; FETAL STEM CELLS; FREEZE DRYING; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GLIOBLASTOMA; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; NANOPARTICLES; NEOPLASTIC STEM CELLS; POLYMERS; SPHEROIDS, CELLULAR; SUCROSE; TIME FACTORS; TRANSFECTION;

EID: 79956301323     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.04.016     Document Type: Article

References (35)

1. DeAngelis L.M. Brain tumors. N Engl J Med 2001, 344(2):114-123.
2. Nguyen T.D., DeAngelis L.M. Brain metastases. Neurol Clin 2007, 25(4):1173-1192. [x-xi].
3. Cancer facts & figures 2010 2010, American Cancer Society, American Cancer Society, Atlanta, Contract No.: March 16.
4. CBTRUS statistical report: primary brain tumors in the United States, 2004-2007 2011, CBTRUS, Available from:, Central Brain Tumor Registry of the United States. http://www.cbtrus.org.
5. Klos K.J., O'Neill B.P. Brain metastases. Neurologist 2004, 10(1):31-46.
6. McGirt M.J., Chaichana K.L., Gathinji M., Attenello F.J., Than K., Olivi A., et al. Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg 2009, 110(1):156-162.
7. McGirt M.J., Mukherjee D., Chaichana K.L., Than K.D., Weingart J.D., Quinones-Hinojosa A. Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme. Neurosurgery 2009, 65(3):463-469. discussion 9-70.
8. McGirt M.J., Than K.D., Weingart J.D., Chaichana K.L., Attenello F.J., Olivi A., et al. Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. J Neurosurg 2009, 110(3):583-588.
9. Jemal A., Thomas A., Murray T., Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002, 52(1):23-47.
10. Cancer advances in focus: brain and other central nervous system cancers 2009, NCI.
11. Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., Taphoorn M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352(10):987-996.
12. Thomas C.E., Ehrhardt A., Kay M.A. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003, 4(5):346-358.
13. Putnam D. Polymers for gene delivery across length scales. Nat Mater 2006, 5(6):439-451.
14. Bhise N.S., Gray R.S., Sunshine J.C., Htet S., Ewald A.J., Green J.J. The relationship between terminal functionalization and molecular weight of a gene delivery polymer and transfection efficacy in mammary epithelial 2-D cultures and 3-D organotypic cultures. Biomaterials 2010, 31(31):8088-8096.
15. Sunshine J., Green J.J., Mahon K., Yang F., Eltoukhy A., Nguyen D.N., et al. Small molecule end group of linear polymer determine cell-type gene delivery efficacy. Adv Mater 2009, 21(48):4947-4951.
16. Green J.J., Langer R., Anderson D.G. A combinatorial polymer library approach yields insight into nonviral gene delivery. Acc Chem Res 2008, 41(6):749-759.
17. Abdelwahed W., Degobert G., Stainmesse S., Fessi H. Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev 2006, 58(15):1688-1713.
18. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444(7120):756-760.
19. Fine H.A. Glioma stem cells: not all created equal. Cancer Cell 2009, 15(4):247-249.
20. Mohyeldin A., Garzon-Muvdi T., Quinones-Hinojosa A. Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell 2010, 7(2):150-161.
21. Zaidi H.A., Kosztowski T., DiMeco F., Quinones-Hinojosa A. Origins and clinical implications of the brain tumor stem cell hypothesis. J Neurooncol 2009, 93(1):49-60.
22. Salmaggi A., Boiardi A., Gelati M., Russo A., Calatozzolo C., Ciusani E., et al. Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype. Glia 2006, 54(8):850-860.
23. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003, 63(18):5821-5828.
24. Strack R.L., Strongin D.E., Bhattacharyya D., Tao W., Berman A., Broxmeyer H.E., et al. A noncytotoxic DsRed variant for whole-cell labeling. Nat Methods 2008, 5(11):955-957.
25. Lois C., Hong E.J., Pease S., Brown E.J., Baltimore D. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 2002, 295(5556):868-872.
26. Guerrero-Cazares H., Chaichana K.L., Quinones-Hinojosa A. Neurosphere culture and human organotypic model to evaluate brain tumor stem cells. Methods Mol Biol 2009, 568:73-83.
27. Pollard S.M., Yoshikawa K., Clarke I.D., Danovi D., Stricker S., Russell R., et al. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 2009, 4(6):568-580.
28. Green J.J., Shi J., Chiu E., Leshchiner E.S., Langer R., Anderson D.G. Biodegradable polymeric vectors for gene delivery to human endothelial cells. Bioconjug Chem 2006, 17(5):1162-1169.
29. Akinc A., Langer R. Measuring the pH environment of DNA delivered using nonviral vectors: implications for lysosomal trafficking. Biotechnol Bioeng 2002, 78(5):503-508.
30. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A 1995, 92(16):7297-7301.
31. Varga C.M., Tedford N.C., Thomas M., Klibanov A.M., Griffith L.G., Lauffenburger D.A. Quantitative comparison of polyethylenimine formulations and adenoviral vectors in terms of intracellular gene delivery processes. Gene Ther 2005, 12(13):1023-1032.
32. Green J.J., Zugates G.T., Tedford N.C., Huang Y., Griffith L.G., Lauffenburger D.A., et al. Combinatorial modification of degradable polymers enables transfection of human cells comparable to adenovirus. Adv Mater 2007, 19(19):2836-2842.
33. Dodds E., Dunckley M.G., Naujoks K., Michaelis U., Dickson G. Lipofection of cultured mouse muscle cells: a direct comparison of Lipofectamine and DOSPER. Gene Ther 1998, 5(4):542-551.
34. Felgner P.L., Gadek T.R., Holm M., Roman R., Chan H.W., Wenz M., et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A 1987, 84(21):7413-7417.
35. Hofland H.E., Shephard L., Sullivan S.M. Formation of stable cationic lipid/DNA complexes for gene transfer. Proc Natl Acad Sci U S A 1996, 93(14):7305-7309.